Sangamo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SGMO for the last quarter is 356.00 k USD, and it's 25.99% lower compared to the previous quarter. The net income of Q2 24 is -36.13 M USD.